An arsenic oxoacid consisting of three hydroxy groups attached to a central arsenic atom.
Chemical ID:
MESH:C032793
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of and affects the localization of NFE2L2 protein]; alpha-Tocopherol inhibits the reaction [Arsenic Trioxide results in decreased expression of NFE2L2 mRNA]; Arsenic Trioxide results in increased expression of and affects the localization of NFE2L2 protein; Arsenic Trioxide results in increased phosphorylation of and affects the localization of NFE2L2 protein; Ascorbic Acid inhibits the reaction [Arsenic Trioxide results in decreased expression of NFE2L2 mRNA]; Buthionine Sulfoximine promotes the reaction [Arsenic Trioxide results in increased expression of and affects the localization of NFE2L2 protein]; crocin inhibits the reaction [Arsenic Trioxide results in decreased expression of NFE2L2 protein]; eriodictyol promotes the reaction [Arsenic Trioxide results in increased expression of NFE2L2 mRNA]; eriodictyol promotes the reaction [Arsenic Trioxide results in increased expression of NFE2L2 protein]; oxymatrine promotes the reaction [Arsenic Trioxide results in increased expression of NFE2L2 protein]; Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased expression of NFE2L2 mRNA]
[Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of and affects the localization of NFE2L2 protein; [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of NFE2L2 mRNA; [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of NFE2L2 protein; [Resveratrol co-treated with Arsenic Trioxide] results in increased expression of NFE2L2 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide affects the localization of NFE2L2 protein]; allicin inhibits the reaction [Arsenic Trioxide results in decreased expression of NFE2L2 protein]; Arsenic Trioxide promotes the reaction [Resveratrol results in increased expression of NFE2L2 protein]; Arsenic Trioxide results in increased expression of and affects the localization of NFE2L2 protein; NFE2L2 mRNA promotes the reaction [Ethionamide results in increased susceptibility to Arsenic Trioxide]; NFE2L2 protein affects the reaction [Arsenic Trioxide results in decreased expression of ACTA2 protein]; NFE2L2 protein affects the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; NFE2L2 protein inhibits the reaction [Arsenic Trioxide results in increased abundance of Reactive Oxygen Species]; NFE2L2 protein promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; NFE2L2 protein promotes the reaction [Arsenic Trioxide results in increased expression of KEAP1 protein]; NFE2L2 protein promotes the reaction [Arsenic Trioxide results in increased expression of NQO1 protein]; NFE2L2 protein promotes the reaction [Arsenic Trioxide results in increased expression of PPARG mRNA]; NFE2L2 protein promotes the reaction [Rosiglitazone results in increased susceptibility to Arsenic Trioxide]; NFE2L2 protein promotes the reaction [Troglitazone results in increased susceptibility to Arsenic Trioxide]; Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of NFE2L2 protein]; Tretinoin inhibits the reaction [Arsenic Trioxide affects the localization of NFE2L2 protein]
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Arsenic Trioxide results in increased expression of NFE2L2 mRNA]; 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Arsenic Trioxide results in increased expression of NFE2L2 protein]; 18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate inhibits the reaction [Arsenic Trioxide results in decreased expression of NFE2L2 protein]; [Arsenic Trioxide co-treated with Grape Seed Proanthocyanidins] results in increased expression of NFE2L2 mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of NFE2L2 protein]; Arsenic Trioxide promotes the reaction [Lutein results in increased expression of NFE2L2 mRNA]; Arsenic Trioxide promotes the reaction [Lutein results in increased expression of NFE2L2 protein]; Lutein promotes the reaction [Arsenic Trioxide results in increased expression of NFE2L2 mRNA]; Lutein promotes the reaction [Arsenic Trioxide results in increased expression of NFE2L2 protein]; NFE2L2 protein affects the reaction [Arsenic Trioxide results in decreased expression of TNF protein]; NFE2L2 protein affects the reaction [Arsenic Trioxide results in increased expression of GCLC mRNA]; NFE2L2 protein affects the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [Arsenic Trioxide results in increased expression of NQO1 mRNA]; SB 203580 inhibits the reaction [Arsenic Trioxide results in increased expression of NFE2L2 mRNA]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of NFE2L2 mRNA]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of NFE2L2 protein]
